Ropes & Gray advised Verastem Oncology on the deal. Verastem Oncology (Nasdaq: VSTM) announced that the company has entered into a discovery and development collaboration with...
Verastem Oncology’s Collaboration with GenFleet Therapeutics
HotSpot Therapeutics’ Global Strategic Collaboration with AbbVie
Ropes & Gray advised HotSpot Therapeutics on the deal. HotSpot Therapeutics announced an exclusive, worldwide collaboration and option to license agreement with AbbVie for HotSpot’s new class...
IDRx’s $122 Million Series A Financing
Ropes & Gray advised IDRx on the deal. Clinical stage precision cancer biopharmaceutical company IDRx announced licensing transactions with Germany-based Merck KGaA and Blueprint Medicines to...